Evaluation of conventional therapeutic methods versus maggot therapy in the evolution of healing of tegumental injuries in Wistar rats with and without diabetes mellitus.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 26976407)

Published in Parasitol Res on March 15, 2016

Authors

Franciéle Souza Masiero1, Patricia Jacqueline Thyssen2

Author Affiliations

1: Department of Microbiology and Parasitology, Federal University of Pelotas-UFPel, POB 354, PC 96010-900, Capão do Leão, Rio Grande do Sul, Brazil.
2: Department of Animal Biology, State University of Campinas-UNICAMP, POB 6109, PC 13083-970, Campinas, São Paulo, Brazil. franmasiero@hotmail.com.

Articles cited by this

Cutaneous wound healing. N Engl J Med (1999) 19.12

The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia (2007) 4.55

Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen (2008) 2.58

Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu Rev Entomol (2000) 2.01

Larva therapy in wound management. J R Soc Med (2000) 1.59

Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br J Dermatol (2003) 1.51

Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci (1997) 1.42

Lower limb amputations in Southern Finland in 2000 and trends up to 2001. Eur J Vasc Endovasc Surg (2004) 0.98

Isolation and identification of two antibacterial agents produced by a strain of Proteus mirabilis isolated from larvae of the screwworm (Cochliomyia hominivorax) (Diptera: Calliphoridae). J Med Entomol (1986) 0.97

Surgical physiology of wound healing: a review. J Postgrad Med (2000) 0.96

Maggot Therapy: The Science and Implication for CAM Part I-History and Bacterial Resistance. Evid Based Complement Alternat Med (2006) 0.92

Maggot debridement therapy in chronic wound care. Hong Kong Med J (2007) 0.92

Amino acid derivatives from Lucilia sericata excretions/secretions may contribute to the beneficial effects of maggot therapy via increased angiogenesis. Br J Dermatol (2009) 0.91

Alloxan diabetes. Physiol Rev (1948) 0.91

Multiple actions of Lucilia sericata larvae in hard-to-heal wounds: larval secretions contain molecules that accelerate wound healing, reduce chronic inflammation and inhibit bacterial infection. Bioessays (2013) 0.89

Evaluation of larval density Cochliomyia macellaria F. (Diptera: Calliphoridae) for therapeutic use in the recovery of tegumentar injuries. Parasitol Res (2015) 0.79

Use of maggot therapy for treating a diabetic foot ulcer colonized by multidrug resistant bacteria in Brazil. Indian J Med Res (2015) 0.78

An assessment of the antibacterial activity in larval excretion/secretion of four species of insects recorded in association with corpses, using Lucilia sericata Meigen as the marker species. Bull Entomol Res (2010) 0.77

A randomized controlled trial of larval therapy for the debridement of leg ulcers: results of a multicenter, randomized, controlled, open, observer blind, parallel group study. Wound Repair Regen (2013) 0.75